Previous studies have reported an oncogenic role for ROR2 in osteosarcoma36, renal cell carcinoma37, and breast cancer38 while it presented a tumour suppressor role in colon cancer39 and hepatocellular carcinoma40. This evidence concerns the gene ROR2 and neoplasm.